EDOC:NSD-Global X Telemedicine & Digital Health ETF (USD)

ETF | Others |

Last Closing

USD 9.52

Change

+0.15 (+1.60)%

Market Cap

USD 0.05B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-27 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
QQQM Invesco NASDAQ 100 ETF

+2.70 (+1.55%)

USD 22.00B
ACWI iShares MSCI ACWI ETF

+0.99 (+0.93%)

USD 19.51B
IBIT iShares Bitcoin Trust

-0.54 (-1.47%)

USD 17.74B
CGABL The Carlyle Group Inc. 4.625% ..

-0.06 (-0.32%)

USD 16.14B
JEPQ JPMorgan Nasdaq Equity Premium..

+0.72 (+1.39%)

USD 11.73B
TBIL Rbb Fund Inc - Us Treasury 3 M..

+0.01 (+0.02%)

USD 3.07B
IBTE iShares iBonds Dec 2024 Term T..

N/A

USD 2.86B
IBTF iShares iBonds Dec 2025 Term T..

N/A

USD 2.25B
USCL iShares Climate Conscious & Tr..

+0.77 (+1.28%)

USD 2.01B
RILYT B. Riley Financial Inc. 6.00% ..

+0.35 (+1.92%)

USD 1.95B

ETFs Containing EDOC

HDOC:CA 98.44 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.93% 17% F 36% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.93% 17% F 36% F
Trailing 12 Months  
Capital Gain -17.65% 17% F 34% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -17.65% 16% F 33% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -13.76% 7% C- 24% F
Dividend Return -13.76% 6% D- 23% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.04% 34% F 82% B
Risk Adjusted Return -91.50% 3% F 8% B-
Market Capitalization 0.05B 50% F 28% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.